METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer
METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22,...